Biliary stent migration represents a significant clinical challenge, occurring when stents inserted to relieve biliary obstructions dislodge from their intended positions. This phenomenon can lead to ...

Please provide your email address to receive an email when new articles are posted on . Endoscopic sphincterotomy performed before endoscopic biliary stenting may prevent post-endoscopic retrograde ...

Time-period from presentation to anticipated surgery: if a patient may undergo pancreaticoduodenectomy within a few days of presentation and is a candidate for surgery, no instrumentation may be ...

Hepatic artery radioembolization (HARE) in the management of progressive metastatic neuroendocrine tumors (NETs): A survival and biochemical response analysis in geriatric (G) and young (Y) ...

There are several types of surgery for bile duct cancer, which are meant to cure cancer or to manage its symptoms. Your bile ducts transport bile from the liver and the gallbladder to the small ...

A bile duct drain, also called biliary drainage, can help treat blocked bile ducts so that bile may flow as it should, helping your liver digest fats. Learn more about biliary drainage, including how ...

Engineering sophomore Summer Cobb, College and Wharton sophomores Amanda Kossoff and Elizabeth Jia, and College and Wharton senior Aarsha Shah won the annual Y-Prize competition (Photo from Wharton).

Self-expanding metal stents have higher acquisition costs than plastic stents, but two randomized studies suggests that metal stents may be the more cost-effective option due to lower complication ...

Cholangiocarcinoma (CCA) is an uncommon malignant tumor arising from the biliary epithelium. The incidence increases with age and usually affects individuals in their 6th or 7th decade of life. Those ...

LONDON--(BUSINESS WIRE)--The biliary stents market is poised to grow by USD 27.81 million during 2020-2024, progressing at a CAGR of about 4% during the forecast period. Worried about the impact of ...

A pilot study of adjuvant chemotherapy with S-1 plus cisplatin for stage II-IV (M0) gastric adenocarcinoma. A phase I/II, nonrandomized, feasibility/safety and efficacy study of the combination of ...